E-LIB Suche - Ergebnisse für: Wilking, Ulla

1

Planning for return to work during the first year after bre..:

Johnsson, Aina ; Kiani, Narsis A. ; Gernaat, Sofie A. M....
Cancer Medicine. 12 (2023) 9 - p. 10840-10850 , 2023

Link: https://doi.org/10.1002/..

2

Risk-adjusted benchmarking of long-term overall survival in..:

Thurell, Jacob ; Manouchehri, Narges ; Fredriksson, Irma...
The Breast. 70 (2023) - p. 18-24 , 2023

Link: https://doi.org/10.1016/..

3

Use of sickness benefits by patients with metastatic breast..:

Altena, Renske ; Gernaat, Sofie A. M. ; Wilking, Ulla...
European Journal of Cancer Care. 31 (2022) 5 - p. , 2022

Link: https://doi.org/10.1111/..

4

The value of anticancer drugs — a regulatory view:

Pignatti, Francesco ; Wilking, Ulla ; Postmus, Douwe...
Nature Reviews Clinical Oncology. 19 (2021) 3 - p. 207-215 , 2021

Link: https://doi.org/10.1038/..

5

Sickness absence and disability pension among swedish women..:

Gernaat, Sofie A. M. ; Johnsson, Aina ; Altena, Renske..
European Journal of Cancer Care. 30 (2020) 1 - p. , 2020

Link: https://doi.org/10.1111/..

6

Societal cost of subcutaneous and intravenous trastuzumab f..:

Olofsson, Sara ; Norrlid, Hanna ; Karlsson, Eva..
The Breast. 29 (2016) - p. 140-146 , 2016

Link: https://doi.org/10.1016/..

7

HER2 status in a population-derived breast cancer cohort: d..:

Wilking, Ulla ; Karlsson, Eva ; Skoog, Lambert...
Breast Cancer Research and Treatment. 125 (2010) 2 - p. 553-561 , 2010

Link: https://doi.org/10.1007/..

8

Risk-adjusted benchmarking of long-term overall survival in..:

Thurell, Jacob ; Manouchehri, Narges ; Fredriksson, Irma...
https://pure.eur.nl/en/publications/92b1d3f9-1e06-412f-9472-d9924581c337. , 2023

Link: https://pure.eur.nl/en/p..

9

Risk-adjusted benchmarking of long-term overall survival in..:

Thurell, Jacob ; Manouchehri, Narges ; Fredriksson, Irma...
https://pure.eur.nl/en/publications/92b1d3f9-1e06-412f-9472-d9924581c337. , 2023

Link: https://pure.eur.nl/en/p..

10

The value of anticancer drugs:a regulatory view:

Pignatti, Francesco ; Wilking, Ulla ; Postmus, Douwe...
https://research.rug.nl/en/publications/223fe2ee-58be-4930-b278-2e661b4d11ff. , 2022

Link: https://hdl.handle.net/1..

11

Studies of targeted therapy in breast cancer using trastuzu..:

Wilking, Ulla
I. HER2 status in a population derived breast cancer cohort – discordances during tumour progression. Wilking, U. Karlsson, E. Skoog, L. Hatschek, T. Lidbrink, E. Elmberger, G. Johansson, H. Lindstrom, L. Bergh, J. Breast Cancer Res Treat. 2011, 125(2): 553-561. ::doi::10.1007/s10549-010-1029-2 ::pmid::20628810 ::isi::000285344000026. , 2011

Link: http://hdl.handle.net/10..

12

HER2 status in a population-derived breast cancer cohort: d..:

Wilking, Ulla ; Karlsson, Eva ; Skoog, Lambert...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s10549-010-1029-2. , 2010

Link: https://hal.archives-ouv..

13

Risk-adjusted benchmarking of long-term overall survival in..:

Jacob Thurell ; Narges Manouchehri ; Irma Fredriksson...
http://www.sciencedirect.com/science/article/pii/S0960977623005040. , 2023

Link: https://doi.org/10.1016/..

14

Planning for return to work during the first year after bre..:

Aina Johnsson ; Narsis A. Kiani ; Sofie A. M. Gernaat...
https://doi.org/10.1002/cam4.5752. , 2023

Link: https://doi.org/10.1002/..

15

Hormone replacement therapy after breast cancer: 10 year fo..:

Fahlén, Mia ; Fornander, Tommy ; Johansson, Hemming...
European Journal of Cancer. 49 (2013) 1 - p. 52-59 , 2013

Link: https://doi.org/10.1016/..